- Home
- HSTM vs MGTX Comparison
HSTM vs MGTX Comparison
Compare HSTM & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HSTM | MGTX |
|---|---|---|
| Founded | 1990 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 634.6M | 665.7M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | HSTM | MGTX |
|---|---|---|
| Price | $21.70 | $8.04 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $28.00 | $23.83 |
| AVG Volume (30 Days) | 248.6K | ★ 421.6K |
| Earning Date | 02-23-2026 | 03-12-2026 |
| Dividend Yield | ★ 0.57% | N/A |
| EPS Growth | ★ 4.75 | N/A |
| EPS | ★ 0.68 | N/A |
| Revenue | ★ $298,590,000.00 | $27,417,000.00 |
| Revenue This Year | $5.13 | N/A |
| Revenue Next Year | $4.89 | $567.62 |
| P/E Ratio | $32.08 | ★ N/A |
| Revenue Growth | 3.68 | ★ 96.83 |
| 52 Week Low | $21.00 | $4.55 |
| 52 Week High | $34.24 | $9.73 |
Technical Indicators
Market Signals| Indicator | HSTM | MGTX |
|---|---|---|
| Relative Strength Index (RSI) | 39.00 | 53.48 |
| Support Level | $21.00 | $7.72 |
| Resistance Level | $21.84 | $8.35 |
| Average True Range (ATR) | 0.59 | 0.41 |
| MACD | 0.03 | 0.09 |
| Stochastic Oscillator | 31.04 | 76.58 |
Price Performance
Historical ComparisonAbout HSTM HealthStream Inc.
HealthStream Inc provides workforce and provider solutions for healthcare organizations. Its reportable segments include Workforce Solutions and Provider Solutions. Workforce development solutions consist of SaaS, subscription-based products that are used by healthcare organizations. Its Provider Solutions products offer healthcare organizations software applications for administering and tracking provider credentialing, privileging, call center and enrollment activities. The company generates a majority of its revenue from Subscription Services.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.